Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Managing movement disorders during the COVID-19 pandemic

Angelo Antonini • 20 May 2020
EAN 2020
Movement Disorders

Angelo Antonini, MD, PhD, University of Padua, Padua, Italy, discusses how the management of patients with movement disorders has changed in light of COVID-19, and what was done to minimize the impact of the virus. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Angelo Antonini

1:50
Clinical highlights in Parkinson's disease
Angelo Antonini • 27 Aug 2023
1:29
Benefits and challenges associated with subcutaneous infusions for Parkinson’s disease
Angelo Antonini • 27 Aug 2023
1:11
Wearables: technological advancements in movement disorder management
Angelo Antonini • 1 Jul 2023
1:36
Parkinson's disease: updates in the disease-modifying space
Angelo Antonini • 1 Jul 2023

Related Videos

1:19
The potential of cell and gene therapy in treating Parkinson’s disease
Fabrizio Stocchi • 7 Mar 2024
4:11
Updates on current Parkinson’s disease clinical trials
Fabrizio Stocchi • 7 Mar 2024
3:42
NfL shows strong prognostic value in pre-manifest Huntington's disease
Natalia E. Owen • 8 Mar 2024
5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
The content of VJNeurology is intended for healthcare professionals